Ludwig Enterprises Files 8-K
Ticker: LUDG · Form: 8-K · Filed: Sep 24, 2024 · CIK: 1960262
| Field | Detail |
|---|---|
| Company | Ludwig Enterprises, Inc. (LUDG) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financial-exhibits
TL;DR
Ludwig Enterprises filed an 8-K, expect updates soon.
AI Summary
Ludwig Enterprises, Inc. filed an 8-K on September 24, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure or exhibits.
Why It Matters
This 8-K filing indicates that Ludwig Enterprises, Inc. has made a regulatory disclosure and submitted financial exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and exhibits, with no immediate indication of significant financial events or risks.
Key Players & Entities
- Ludwig Enterprises, Inc. (company) — Registrant
- September 24, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is September 24, 2024.
What is the company's principal executive office address?
The company's principal executive office is located at 1749 Victorian Avenue, #C-350, Sparks, Nevada, 89431.
What is the telephone number for Ludwig Enterprises, Inc.?
The registrant's telephone number is 786-235-9026.
What is the SIC code for Ludwig Enterprises, Inc.?
The Standard Industrial Classification (SIC) code for Ludwig Enterprises, Inc. is 8071, which corresponds to Medical Laboratories.
Filing Stats: 641 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-09-24 09:01:31
Filing Documents
- ludg_8k.htm (8-K) — 34KB
- ex99_1.htm (EX-99.1) — 6KB
- 0001903596-24-000596.txt ( ) — 207KB
- ludg-20240924.xsd (EX-101.SCH) — 3KB
- ludg-20240924_lab.xml (EX-101.LAB) — 33KB
- ludg-20240924_pre.xml (EX-101.PRE) — 22KB
- ludg_8k_htm.xml (XML) — 3KB
01 Regulation FD
Item 7.01 Regulation FD Disclosure. On September 24, 2024, the Company issued a press release announcing an AI-Powered Cancer Screening Technology. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The furnishing of the press release is not an admission as to the materiality of any information therein. The information contained in the press release is summary information that is intended to be considered in the context of more complete information included in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC") and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. The information in this Item 7.01 of this Current Report on Form 8-K and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the press release shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 104 Press Release dated September 24, 2024 Cover Page Interactive Data File (embedded within the Inline XBRL Document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 24, 2024. LUDWIG ENTERPRISES, INC. By: /s/ Jose Antonio Reyes Jose Antonio Reyes Chief Executive Officer